Feedback / Questions
RiMO-301 - Coordination Pharma
Opdivo (nivolumab) - Ono Pharma, BMS
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT05838729
Sep 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next